Wednesday, June 1, 2016

BRIEF-Allergan receives FDA approval to market Juvéderm Volbella XC

* Received approval from U.S. Food And Drug Administration

(FDA) to market Juvéderm Volbella XC

Read more

No comments:

Post a Comment